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FOR THE HEALTH,A GING, AND BODY
COMPOSITION STUDY
OBJECTIVE — A loss of skeletal muscle mass is frequently observed in older adults. The aim
ofthestudywastoinvestigatetheimpactoftype2diabetesonthechangesinbodycomposition,
with particular interest in the skeletal muscle mass.
RESEARCH DESIGN AND METHODS — We examined total body composition with
dual-energy X-ray absorptiometry annually for 6 years in 2,675 older adults. We also measured
mid-thighmusclecross-sectionalarea(CSA)withcomputedtomographyinyear1andyear6.At
baseline,75-goralglucosechallengetestswereperformed.Diagnoseddiabetes(n402,15.0%)
was identiﬁed by self-report or use of hypoglycemic agents. Undiagnosed diabetes (n  226,
8.4%) was deﬁned by fasting plasma glucose (7 mmol/l) or 2-h postchallenge plasma glucose
(11.1mmol/l).Longitudinalregressionmodelswereﬁttoexaminetheeffectofdiabetesonthe
changes in body composition variables.
RESULTS — Older adults with either diagnosed or undiagnosed type 2 diabetes showed
excessivelossofappendicularleanmassandtrunkfatmasscomparedwithnondiabeticsubjects.
ThighmuscleCSAdeclinedtwotimesfasterinolderwomenwithdiabetesthantheirnondiabetic
counterparts. These ﬁndings remained signiﬁcant after adjusting for age, sex, race, clinic site,
baseline BMI, weight change intention, and actual weight changes over time.
CONCLUSIONS — Type 2 diabetes is associated with excessive loss of skeletal muscle and
trunk fat mass in community-dwelling older adults. Older women with type 2 diabetes are at
especially high risk for loss of skeletal muscle mass.
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ge-related loss of skeletal muscle
mass or sarcopenia results in de-
creased skeletal muscle strength,
mobility limitations, physical disability,
and eventually high mortality among the
elderly (1–3). However, little is known
about the causes or risk factors associated
with loss of skeletal muscle mass in older
adults. In addition, although weight gain
and accumulation of abdominal fat have
been known as strong risk factors for the
development of type 2 diabetes (4), the
changesinbodycompositionaftertheon-
set of diabetes are not well documented.
We have observed cross-sectionally that
older adults with type 2 diabetes have an
altered body composition and low skele-
tal muscle strength compared with non-
diabetic older adults (5). We also
reported that older adults with type 2 di-
abetes lost their knee extensor strength
more rapidly than their nondiabetic
counterparts (6).
The effects of type 1 diabetes on pro-
tein metabolism seem to be clear, as
insulin deprivation causes a profound in-
crease in catabolism, especially in skeletal
muscle (7,8). However, the effect of type
2 diabetes on protein metabolism is less
clear, since the results of previous studies
areinconsistent(9–12).Fewstudieshave
examined the effect of type 2 diabetes on
the quantity of skeletal muscle mass in
humans.
In the Health, Aging, and Body Com-
position Study (Health ABC Study), we
assessed the changes in total and regional
leanandfatmassover6yearswithprecise
measures of body composition with dual-
energy X-ray absorptiometry (DEXA) and
computed tomography (CT). The aim of
the study was to investigate the impact of
type 2 diabetes on the changes in body
composition, with particular interest on
the skeletal muscle, in community-
dwelling well-functioning older adults.
We hypothesized that older adults with
type 2 diabetes would show more loss of
lean skeletal muscle mass than older
adults without diabetes.
RESEARCH DESIGN AND
METHODS
Study population
The Health ABC cohort consisted of well-
functioning community-dwelling older
adults age 70–79 years. (Detailed infor-
mation on enrollment can be found else-
where [5].) The ﬂow of subjects for the
DEXA study and the CT study is summa-
rized in Fig. 1. All participants gave writ-
teninformedconsentbeforeparticipating
inthestudy.Theconsentformsandstudy
protocols were approved by the institu-
tional review boards at each ﬁeld center.
Assessment of diabetes status
At baseline, diagnosed diabetes was de-
ﬁned by a report of physician-diagnosed
type 2 diabetes or the current use of oral
hypoglycemic agents or insulin with on-
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75-g oral glucose challenge tests for all
participants without diagnosed diabetes.
Undiagnosed diabetes was deﬁned by a
fasting plasma glucose concentration
7.0 mmol/l or a 2-h postchallenge
plasma glucose 11.1 mmol/l. The aver-
age duration of diagnosed diabetes was
13.3 10.9 years from the time of diagno-
sis. Plasma glucose was measured by an au-
tomated glucose oxidase reaction (Vitros
950 analyzer; Johnson & Johnson, Roches-
ter, NY). A1C was measured by the enzy-
matic method (Bio-Rad, Hercules, CA).
Body composition by DEXA
Bodyweightandheightweremeasuredin
patients wearing a hospital gown and
without shoes on a calibrated balance
beam scale and stadiometer, respectively,
and BMI was calculated as weight in kilo-
grams divided by the square of height in
meters. We used fan-beam dual-energy
X-rayabsorptiometry(modelQDR4.500,
software version 8.21; Hologic, Bedford,
MA)tomeasuretotalbodymassandbody
composition. Total body fat and fat-free
mass were measured and separated into
trunk and appendicular components.
Then, bone mineral content was sub-
tractedfromthetotalandregionalfat-free
masstodeﬁnetotalandregionalnonbone
lean mass. Appendicular lean mass was
calculated as the sum of lean soft tissue
(nonfat, nonbone) mass in the arms and
legs, which represents primarily skeletal
musclemassintheextremities.Thevalid-
ity and reproducibility of the body com-
position data in the Health ABC Study
were previously reported (13,14).
Body composition by CT
Axial CT scans at the abdomen and mid-
thigh levels were obtained at baseline
(year 1) and 5 years later (year 6). CT
images were acquired in either Pitts-
burgh, Pennsylvania (9800 Advantage;
General Electric, Milwaukee, WI), or
Memphis, Tennessee (Somaton Plus;
Simens, Iselin, NJ, or PQ2000S; Picker,
Cleveland, OH). We used the mid-thigh
muscle cross-sectional area (CSA) as an
indicator of skeletal muscle mass. Quality
control ensured the reproducibility and
quality of the repeated CT scans. Scans
with any artifacts or poor quality were re-
moved, abdominal scans obtained at or
above the L3/L4 level or at or below the
L5/S1 level were removed, and mid-thigh
scans obtained from a different leg or a
slice location on the femur 2c mo ft h e
baseline scan were removed.
Inﬂammatory cytokines
Interleukin(IL)-6andtumornecrosisfac-
tor (TNF)- were measured in duplicate
with an ultrasensitive enzyme-linked im-
munosorbent assay (R&D Systems, Min-
neapolis, MN). The lower limit of
detection was 0.10 pg/ml for IL-6 and
0.18pg/mlforTNF-,withcoefﬁcientsof
variation of 6.3 and 16.0%, respectively.
Statistical analyses
Baseline characteristics of the cohort are
presented separately for three groups de-
ﬁned by baseline diabetes status (Table 1).
ANOVA, 
2, and Kruskal-Wallis tests
were used to examine differences in the
descriptive characteristics of the study
population. The longitudinal changes in
bodycompositionwereanalyzedwiththe
generalized estimating equation model
(usingSASVersion8.1ProcGenmod)de-
veloped by Liang and Zeger (15). This
method simultaneously examines the
cross-sectional relation between each in-
dependent variable and body composi-
tion and the longitudinal relation
between these variables and changes in
body composition over time. Included in
themodelsarepotentialconfoundingfac-
torsthatareassociatedwithbodycompo-
sition and its changes over time. The
initial model included age, sex, race,
Figure 1—Flow of study population: the Health ABC Study.
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tion, weight loss intention assessed by
questionnaire at each year, two dummy
variables for new diabetes (new-DM) and
known diabetes (known-DM), examina-
tionyear(YR)asatime-dependentcovari-
ate, and cross-product terms between YR
andthetwodummyvariablesfordiabetes
(YR  new-DM, YR  known-DM) to as-
sess changes in body composition over
time between groups. Interactions be-
tween sex, race, and clinic site with dia-
betes variables (e.g., sex  new-DM 
YR) were assessed. There was no signiﬁ-
cantinteractioneffect(P0.10)between
sex, race, or clinic site with diabetes vari-
ables on changes in body composition.
Theﬁnalmodelincludedchangesinbody
weight at each examination year as time-
dependent covariates to examine the ef-
fects of diabetes on the changes of each
body composition parameters while ad-
justing for the changes in overall body
weight.
For the CT-derived body composi-
tion data, changes in abdominal subcuta-
neousfat,visceralfat,thighsubcutaneous
fat, thigh intermuscular fat, and thigh
muscleCSAwerecalculatedinbothabso-
lute terms (year 6 value  year 1 value)
and relative terms (percent change from
baseline).Differencesbetweenthegroups
were assessed by general linear models
controlling for age, sex, race, clinic site,
and baseline values when using absolute
changes. We found a signiﬁcant interac-
tion effect (P  0.10) of sex and diabetes
variables on the changes in thigh muscle
area. Therefore, further analyses were
stratiﬁed by sex for CT data. Additional
adjustments were made for baseline BMI,
weight change, IL-6, and TNF-.W e
used Bonferroni correction methods for
multiple comparisons between groups. A
P value of 0.05 was accepted as statisti-
cally signiﬁcant. The analyses were per-
formed with SPSS (version 12.0.0; SPSS,
Chicago, IL) and SAS (version 8.1; SAS
Institute, Cary, NC).
RESULTS— The annual changes in
eachbodycompositionparameteradjust-
ing for age, sex, race, clinic site, baseline
BMI, and weight loss intention are sum-
marized in Table 2. Loss of total body
mass was the most profound in older
adults with undiagnosed diabetes fol-
lowed by diagnosed diabetes and those
without diabetes (435  79 vs.
293  72 vs. 193  22 g/year, re-
spectively,P0.01).Mostofthedeclines
in total body mass were from lean mass,
particularly in the extremities (appendic-
ular lean mass). The annual declines in
appendicular lean mass were higher in
older adults with undiagnosed and diag-
nosed diabetes than in those without dia-
betes. Total and trunk fat mass also
declined in older adults with undiag-
nosed and diagnosed diabetes in contrast
tonochangeoraslightgaininthosewith-
out diabetes (Table 2).
Model 2 in Table 2 shows dispropor-
tional changes in body composition. In
general, lean skeletal mass decreased but
fat mass increased over time in all three
groups. The rates of decline in total and
appendicular lean mass were greater in
Table 1—Characteristics of participants by baseline diabetes status in the Health ABC Study
Without
diabetes
Undiagnosed
diabetes
Diagnosed
diabetes P*
n 2047 226 402
Sociodemographic
Age (years) 73.6  2.9 73.7  2.8 73.6  2.7 NS
Men (%) 47.6 55.8 55.5 0.001
Blacks (%) 36.7 42.0 57.7 0.001
Body composition
BMI (kg/m
2) 26.8  4.6 28.5  4.8 29.1  4.7 0.001
Total body mass (kg) 74.2  14.4 79.9  15.8 81.2  14.0 0.001
Total lean mass (kg) 45.9  9.8 49.1  10.3 50.4  9.3 0.001
Trunk lean 23.1  4.8 24.8  5.1 25.3  4.7 0.001
Appendicular lean 19.8  4.9 21.1  5.1 21.9  4.6 0.001
Total fat mass (kg) 26.0  8.4 28.4  9.0 28.5  8.7 0.001
Trunk fat 12.9  4.6 14.9  5.3 15.0  5.0 0.001
Appendicular fat 12.6  4.5 13.0  4.6 12.8  4.3 NS
Biochemical
Fasting glucose (mmol/l) 5.14  0.52 6.98  2.19 8.56  3.26 0.001
A1C (%) 6.0  0.5 6.9  1.3 8.0  1.6 0.001
IL-6 (pg/ml)† 1.72 (1.17–2.62) 2.10 (1.38–3.08) 2.16 (1.52–3.19) 0.001
TNF- (pg/ml)† 3.08 (2.38–3.95) 3.28 (2.49–4.34) 3.46 (2.58–4.42) 0.001
Data are means  SD, proportions, or median (interquartile range). NS, not signiﬁcant; *P values from
ANOVA or 
2 tests; †Kruskal-Wallis tests.
Table2—AnnualchangesinbodycompositionassessedwithDEXAbybaselinediabetesstatus
in the Health ABC Study
Without
diabetes
Undiagnosed
diabetes
Diagnosed
diabetes
n 2047 226 402
Model 1
Total body mass (g/year) 193  22 435  79* 293  72
Total lean mass (g/year) 198  10 340  37* 222  29
Trunk lean (g/year) 44  6 103  22* 27  16
Appendicular lean (g/year) 150  5 226  20* 187  16†
Total fat mass (g/year) 25  16 94  53† 66  53
Trunk fat (g/year) 44  10 39  35† 34  32†
Appendicular fat (g/year) 17  7 51  24 27  24
Model 2
Total lean mass (g/year) 125  7 186  25† 106  20
Trunk lean (g/year) 10  5 32  17 26  13†
Appendicular lean (g/year) 113  4 149  14† 130  11
Total fat mass (g/year) 163  7 203  23 160  20
Trunk fat (g/year) 125  5 136  17 96  14†
Appendicular fat (g/year) 41  47 3  14† 64  12
Data are adjusted means  SE estimated by generalized estimating equations. Model 1: adjustment for age,
sex,race,clinicsite,baselineBMI,andweightlossintention;model2:furtheradjustmentforchangesinbody
weight. *P  0.01, †P  0.05 vs. those without diabetes.
Park and Associates
care.diabetesjournals.org DIABETES CARE, VOLUME 32, NUMBER 11, NOVEMBER 2009 1995older adults with undiagnosed diabetes
than in those without diabetes, even after
adjusting for the changes in body weight
over time. In older adults with diagnosed
diabetes, trunk lean and fat mass were
slightly increased when the changes in
body weight were accounted for.
Longitudinalchangesinthighmuscle
massassessedbyCTscanaresummarized
in Table 3. Because we found a signiﬁcant
interaction effect of sex and diabetes sta-
tus on the changes in thigh muscle area
(P  0.044), the results were shown by
sex. Men showed more rapid declines in
thighmuscleCSAthanwomeninallthree
groups. Even in men without diabetes,
the decline in thigh muscle CSA was
about two- to threefold higher than in
women without diabetes (13.0  0.8
vs. 5.1  0.5 cm
2 in 5 years). In men,
thedeclinesinthighmuscleCSAwerenot
signiﬁcantly different between groups.
However,inwomen,thedeclinesinthigh
muscle CSA were signiﬁcantly higher in
those with either diagnosed or undiag-
nosed diabetes than in their nondiabetic
counterparts (11.1  1.4 and 11.7 
1.8 vs. 5.1  0.5 cm
2, P  0.001). Ad-
justments for baseline weight, weight
change over 5 years, IL-6, and TNF- at-
tenuated the rapid declines in thigh mus-
cle CSA. But older women with either
diagnosed or undiagnosed diabetes still
showed about a twofold greater loss of
thigh muscle CSA than their nondiabetic
counterpartswhenadjustedforthediffer-
ences in body size, weight changes, and
inﬂammatorycytokines(models2–4,Ta-
ble 3).
CONCLUSIONS— In this study, we
foundrapiddeclinesinappendicularlean
mass in older adults with type 2 diabetes,
especially in undiagnosed cases. The de-
clines in appendicular lean mass, which
represent skeletal muscle mass, are inde-
pendent of weight changes over time,
conﬁrming an excessive loss of skeletal
muscle mass in older adults with type 2
diabetes. The CT data reafﬁrmed the
rapid loss of thigh muscle mass in older
adults with type 2 diabetes, although it
was signiﬁcant only in women.
We found a signiﬁcant interaction ef-
fect of sex and diabetes on the changes in
thigh muscle mass assessed by CT scan.
Older women with type 2 diabetes
showed about twofold rapid declines in
thigh muscle mass compared with nondi-
abetic women. It is interesting that the
amount of thigh muscle lost in women
withtype2diabeteswascomparablewith
that of men without diabetes, suggesting
that women with type 2 diabetes lost the
beneﬁcial effect of female sex on preserv-
ing lean muscle mass. The ﬁnding of our
study on sex difference is very consistent
with previous studies showing that de-
clines in muscle mass were almost always
greater in men than in women (16,17).
Higher background declines of thigh
muscle mass in older men without dia-
betes may make it difﬁcult to detect
subtle additional changes associated
with diabetes. It is also possible that
survival bias or selection bias for year 6
CT measurement may obscure the true
association, particularly in men. Our
previous report on the changes of mus-
clestrengthinthesamepopulationsug-
gested that differential follow-up rate or
nonrandom missing data might inﬂu-
ence the results biased to the null (6).
The reason for an accelerated loss of
muscle mass in older adults with type 2
diabetes is not clear. It can be postulated
that metabolic abnormalities in type 2 di-
abetes may negatively affect muscle mass.
Although the effect on protein metabo-
lism is not as clear as it is in type 1 diabe-
tes, the net balance of body protein
metabolism is diminished in type 2 dia-
betes (9–11). Insulin resistance in type 2
diabetes may also result in the reduced
synthesis of whole-body proteins (12).
Interestingly, we found that those
with undiagnosed diabetes showed the
greatest declines in appendicular lean
mass, suggesting that the effect of type 2
diabetesonskeletalmusclemassseemsto
be manifested in the early stages of the
disease. In diagnosed cases, the long du-
ration of diabetes (average 13.3 years)
could already affect the baseline body
composition, which might make it difﬁ-
cult to detect further changes. It is also
possible that various treatments in sub-
jects with diagnosed diabetes might mod-
ify the association of diabetes and the
changes in body composition. For exam-
ple, treatment with sulfonylurea or insu-
lin is often accompanied by improved
protein metabolism (18,19). Thiazo-
lidinediones may also result in weight
gain and/or edema, which may obscure
accurate assessments of body composi-
tion changes. Unfortunately, we were un-
able to evaluate the effects of various
medications in the current study because
ofthesmallnumbersinanyonetreatment
and the substantial changes in treatment
during follow-up.
There are several limitations in our
study. Although we have shown the tem-
poral relationship between baseline dia-
betes status and longitudinal changes in
muscle mass, it does not conﬁrm causal-
ity. We could not identify the factors as-
sociated with the rapid loss of muscle
mass in older adults with type 2 diabetes
other than those in the early stages of di-
abetes, as evidenced in cases of undiag-
nosed diabetes. Our study was not
designedtoexaminetheeffectofglycemic
control, speciﬁc treatments, comorbidi-
ties, and other hormones, etc. These
would be better addressed in a study of
diabetes with a detailed characterization
of diabetic management over time.
Despite any limitations, the results of
our study have important implications
Table 3—Longitudinal changes in thigh muscle CSA (cm
2) by baseline diabetes status in the
Health ABC Study, stratiﬁed by sex
Without
diabetes
Undiagnosed
diabetes
Diagnosed
diabetes P
n 1,290 125 214
Men
Model 1 13.0  0.8 17.6  2.2 14.0  1.7 0.153
Model 2 13.3  0.7 17.0  2.2 13.1  1.7 0.282
Model 3 13.4  0.6 15.2  1.7 13.4  1.3 0.632
Model 4 13.6  0.6 15.9  1.9 12.8  1.4 0.411
Women
Model 1 5.1  0.5 11.7  1.8* 11.1  1.4* 0.001
Model 2 5.2  0.5 11.3  1.8* 10.6  1.4* 0.001
Model 3 5.3  0.4 10.8  1.4* 10.0  1.1* 0.001
Model 4 5.2  0.4 10.6  1.5* 9.3  1.2* 0.001
DataareadjustedmeansSE.Model1:adjustedforage,race,andclinicsite;model2:additionallyadjusted
for baseline body weight; model 3: additionally adjusted for changes in body weight; and model 4: addi-
tionally adjusted for IL-6 and TNF-.* P  0.01 vs. those without diabetes after Bonferroni correction for
multiple comparisons.
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abetes increase with age. Both conditions
often remain unrecognized since one-
third of type 2 diabetic subjects are still
undiagnosed (20,21). If older adults with
undiagnosed type 2 diabetes were left un-
treated, they would be at higher risk for
developing sarcopenia. Excessive loss of
muscle mass in older adults with type 2
diabetes may result in poor muscle
strength, functional limitations, and
physical disability. Future research
should ﬁnd the factors responsible for ex-
cessive loss of lean mass in older adults
with type 2 diabetes and develop strate-
gies to prevent the adverse outcomes of
sarcopenia in this high-risk population
(22). In conclusion, type 2 diabetes is as-
sociated with the excessive loss of skeletal
muscle mass in older adults. Older adults
with undiagnosed diabetes are at particu-
larly high risk for the loss of skeletal mus-
cle mass.
Acknowledgments— This study was sup-
ported by contracts N01-AG-6-2101, N01-
AG-6-2103, and N01-AG-6-2106 and in part
bytheIntramuralResearchProgramoftheNa-
tionalInstitutesofHealthNationalInstituteon
Aging.
No potential conﬂicts of interest relevant to
this article were reported.
References
1. Landers KA, Hunter GR, Wetzstein CJ,
Bamman MM, Weinsier RL. The interre-
lationship among muscle mass, strength,
and the ability to perform physical tasks
of daily living in younger and older
women. J Gerontol A Biol Sci Med Sci
2001;56:B443–B448
2. VisserM,GoodpasterBH,KritchevskySB,
NewmanAB,NevittM,RubinSM,Simon-
sick EM, Harris TB. Muscle mass, muscle
strength, and muscle fat inﬁltration as
predictorsofincidentmobilitylimitations
in well-functioning older persons. J Ger-
ontol A Biol Sci Med Sci 2005;60:324–
333
3. Newman AB, Kupelian V, Visser M, Simon-
sick EM, Goodpaster BH, Kritchevsky SB,
Tylavsky FA, Rubin SM, Harris TB, on be-
half of the Health, Aging and Body Compo-
sition Study Investigators. Strength, but not
muscle mass, is associated with mortality in
the health, aging and body composition
study cohort. J Gerontol A Biol Sci Med Sci
2006;61: 72–77
4. Koh-Banerjee P, Wang Y, Hu FB, Spiegelman
D, Willett WC, Rimm EB. Changes in body
weightandbodyfatdistributionasriskfactors
for clinical diabetes in US men. Am J Epide-
miol 2004;159:1150–1159
5. Park SW, Goodpaster BH, Strotmeyer ES,
De Rekeneire N, Harris TB, Schwartz AV,
Tylavsky FA, Newman AB. Decreased
muscle strength and quality in older
adults with type 2 diabetes: the Health,
Aging, and Body Composition Study.
Diabetes 2006;55:1813–1818
6. Park SW, Goodpaster BH, Strotmeyer ES,
Kuller LH, Broudeau R, Kammerer C, De
RekeneireN,HarrisTB,SchwartzAV,Ty-
lavskyFA,ChoY-W,NewmanAB,forthe
Health, Aging, and Body Composition
Study. Accelerated loss of skeletal muscle
strength in older adults with type 2 dia-
betes: the Health, Aging, and Body Com-
position Study. Diabetes Care 2007;30:
1507–1512
7. Charlton M, Nair KS. Protein metabolism
in insulin-dependent diabetes mellitus. J
Nutr 1998;128(S2):323S–327S
8. Karakelides H, Asmann YW, Bigelow ML,
Short KR, Dhatariya K, Coenen-Schimke
J, Kahl J, Mukhopadhyay D, Nair KS. Ef-
fect of insulin deprivation on muscle mi-
tochondrial ATP production and gene
transcript levels in type 1 diabetic sub-
jects. Diabetes 2007;56:2683–2689
9. DenneSC,BrechtelG,JohnsonA,Liechty
EA,BaronAD.Skeletalmuscleproteolysis
is reduced in noninsulin-dependent dia-
betes mellitus and is unaltered by eugly-
cemic hyperinsulinemia or intensive
insulin therapy. J Clin Endocrinol Metab
1995;80:2371–2377
10. Halvatsiotis P, Short KR, Bigelow M, Nair
KS. Synthesis rate of muscle proteins,
musclefunctions,andaminoacidkinetics
intype2diabetes.Diabetes2002;51:2395–
2404
11. Gougeon R, Morais JA, Chevalier S,
Pereira S, Lamarche M, Marliss EB. Deter-
minantsofwhole-bodyproteinmetabolism
in subjects with and without type 2 diabe-
tes. Diabetes Care 2008;31:128–133
12. PereiraS,MarlissEB,MoraisJA,Chevalier
S, Gougeon R. Insulin resistance of pro-
tein metabolism in type 2 diabetes. Dia-
betes 2008;57:56–63
13. Visser M, Fuerst T, Lang T, Salamone L,
Harris TB. Validity of fan beam dual-en-
ergy x-ray absorptiometry for measuring
fat-free and leg muscle mass. Health, Ag-
ing, and Body Composition Study–Dual-
Energy X-ray Absorptiometry and Body
Composition Working Group. J Appl
Physiol 1999;87:1513–1520
14. Tylavsky FA, Lohman TG, Dockrell M,
Lang T, Schoeller DA, Wan JY, Fuerst T,
Cauley JA, Nevitt M, Harris TB. Compar-
ison of the effectiveness of 2 dual-energy
X-ray absorptiometers with that of total
bodywaterandcomputedtomographyin
assessing changes in body composition
during weight change. Am J Clin Nutr
2003;77:356–363
15. Liang KY, Zeger SL. Longitudinal data
analysis using generalized linear models.
Biometrica 1986;73:13–22
16. Visser M, Pahor M, Tylavsky F, Kritchev-
skySB,CauleyJA,NewmanAB,BluntBA,
Harris TB. One- and two-year change in
bodycompositionasmeasuredbyDXAin
a population-based cohort of older men
and women. J Appl Physiol 2003;94:
2368–2374
17. Hughes VA, Frontera WR, Roubenoff R,
Evans WJ, Singh MA. Longitudinal
changes in body composition in older
men and women: role of body weight
change and physical activity. Am J Clin
Nutr 2002;76:473–481
18. Gougeon R, Styhler K, Morais JA, Jones
PJ, Marliss EB. Effects of oral hypoglyce-
mic agents and diet on protein metabo-
lism in type 2 diabetes. Diabetes Care
2000;23:1–8
19. Gougeon R, Marliss EB, Jones PJ, Pen-
charz PB, Morais JA. Effect of exogenous
insulinonproteinmetabolismwithdiffer-
ing nonprotein energy intakes in type 2
diabetes mellitus. Int J Obes Relat Metab
Disord 1998;22:250–261
20. Wild S, Roglic G, Green A, Sicree R, King
H. Global prevalence of diabetes: esti-
mates for the year 2000 and projections
for 2030. Diabetes Care 2004;27:1047–
1053
21. Franse LV, Di Bari M, Shorr RI, Resnick
HE, van Eijk JT, Bauer DC, Newman AB,
Pahor M, for the Health, Aging, and Body
Composition Study Group. Type 2 diabe-
tesinolderwell-functioningpeople:Who
is undiagnosed? Data from the Health,
Aging, and Body Composition Study.
Diabetes Care 2001;24:2065–2070
22. Lanza IR, Short DK, Short KR, Raghava-
kaimal S, Basu R, Joyner MJ, McConnell
JP,NairKS.Enduranceexerciseasacoun-
termeasure for aging. Diabetes 2008;57:
2933–2942
Park and Associates
care.diabetesjournals.org DIABETES CARE, VOLUME 32, NUMBER 11, NOVEMBER 2009 1997